<DOC>
	<DOCNO>NCT00889187</DOCNO>
	<brief_summary>The purpose research study determine possible deliver high dose radiation one week also give drug capecitabine treatment pancreatic cancer prior surgery , determine treatment give safely treatment pancreatic cancer prior surgery , determine treatment improve local control pancreatic cancer prior surgery compare historical control standard treatment .</brief_summary>
	<brief_title>Neoadjuvant Accelerated Short Course Radiation Therapy With Photons Capecitabine Resectable Pancreatic Cancer</brief_title>
	<detailed_description>- Since look best schedule dose radiation administer safely without severe unmanageable side effect participant pancreatic cancer , everyone participates research study receive dose radiation therapy . The dose participant get depend upon number participant enrol study well tolerated dos . - Radiation treatment day begin weekday continue total 7 12 day . Capecitabine pills begin morning first day radiation take twice day 10 consecutive weekday , participant receiving radiation . - Blood test , vital sign physical exam perform day 1 day 15 either day 7 , 8 , 9 . - Surgery perform 1 3 week completion radiation capecitabine .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Cytologic histologic proof pancreatic ductal carcinoma require prior treatment . No evidence metastatic disease determine chest CT scan , abdominal CT scan ( MRI gadolinium and/or manganese ) , patient must stag physical exam , chest CT , abdominal CT intravenous contrast . Only potentially resectable patient eligible . Potentially resectable define : ) extrapancreatic disease , b ) evidence ( CT ) involvement celiac axis superior mesenteric artery , c ) evidence ( CT MRI ) occlusion superior mesenteric vein superior mesentericportal venous confluence . 18 year age old ECOG Performance status 0 1 Women child bear potential must practice adequate contraception refrain breast feeding . Female patient must negative pregnancy test within 7 day treatment Lab value specify protocol Patients hepatic peritoneal metastasis detect image laparoscopy prior chemoradiation Serious concomitant systemic disorder incompatible study , significant cardiac pulmonary morbidity , ongoing infection manifest fever Pregnant lactating woman Life expectancy &lt; 3 month Serious , uncontrolled , concurrent infection ( ) Any prior chemotherapy radiation treatment patient 's pancreatic tumor Treatment cancer within last five year , except cure nonmelanoma skin cancer treat situ cervical cancer Clinically significant cardiac disease myocardial infarction within last 12 month Other serious uncontrolled medical condition investigator feel might compromise study participation Lack physical integrity upper gastrointestinal tract malabsorption syndrome Known , exist uncontrolled coagulopathy Unwillingness participate inability comply protocol duration study Any prior fluoropyrimidine therapy ( unless give adjuvant set complete least 6 month earlier ) Prior unanticipated severe reaction fluoropyrimidine therapy , know hypersensitivity 5fluorouracil know DPD deficiency Participation investigational drug study within 4 week precede start study treatment History uncontrolled seizure , central nervous system disorder psychiatric disability judge investigator clinically significant , preclude informed consent , interfere compliance oral drug intake Major surgery , exclude laparoscopy , within 4 week start study treatment , without complete recovery Patients cimetidine decrease clearance 5FU . Another H2blocker proton pump inhibitor may substitute study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>radiation therapy</keyword>
	<keyword>capecitabine</keyword>
</DOC>